X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4184) 4184
Newsletter (178) 178
Magazine Article (34) 34
Newspaper Article (31) 31
Book Chapter (14) 14
Dissertation (9) 9
Publication (8) 8
Conference Proceeding (3) 3
Paper (2) 2
Web Resource (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
moxifloxacin (4031) 4031
humans (2020) 2020
index medicus (1885) 1885
fluoroquinolones (1351) 1351
pharmacology & pharmacy (1239) 1239
male (984) 984
microbiology (975) 975
female (952) 952
levofloxacin (832) 832
infectious diseases (819) 819
adult (676) 676
microbial sensitivity tests (664) 664
antibiotics (657) 657
ciprofloxacin (645) 645
middle aged (613) 613
tuberculosis (585) 585
pharmacokinetics (529) 529
animals (478) 478
anti-bacterial agents - pharmacology (454) 454
gatifloxacin (447) 447
anti-bacterial agents - therapeutic use (444) 444
aged (443) 443
treatment outcome (410) 410
analysis (398) 398
ophthalmology (394) 394
research (372) 372
drug therapy (367) 367
drugs (311) 311
health aspects (308) 308
fluoroquinolones - pharmacology (304) 304
drug resistance (301) 301
anti-bacterial agents - administration & dosage (293) 293
resistance (290) 290
anti-infective agents - pharmacology (284) 284
quinolines - therapeutic use (284) 284
in-vitro (282) 282
quinolones (279) 279
aza compounds - therapeutic use (277) 277
mycobacterium-tuberculosis (275) 275
dosage and administration (274) 274
infection (269) 269
infections (268) 268
ofloxacin (268) 268
young adult (263) 263
care and treatment (261) 261
antitubercular agents - therapeutic use (254) 254
mycobacterium tuberculosis - drug effects (254) 254
drug resistance, bacterial (247) 247
bacteria (244) 244
drug therapy, combination (243) 243
safety (239) 239
pulmonary tuberculosis (238) 238
quinolines - pharmacology (238) 238
rifampin (238) 238
susceptibility (238) 238
fluoroquinolones - therapeutic use (235) 235
aza compounds - pharmacology (229) 229
therapy (228) 228
adolescent (222) 222
quinolines - administration & dosage (221) 221
aza compounds (220) 220
fluoroquinolone (217) 217
aza compounds - administration & dosage (215) 215
quinolines (215) 215
pharmacology (213) 213
surgery (210) 210
respiratory system (208) 208
endophthalmitis (206) 206
immunology (206) 206
aged, 80 and over (200) 200
efficacy (200) 200
dose-response relationship, drug (197) 197
risk factors (194) 194
streptococcus-pneumoniae (192) 192
anti-bacterial agents - pharmacokinetics (191) 191
clinical trials (190) 190
internal medicine (188) 188
clarithromycin (186) 186
pneumonia (185) 185
medicine, general & internal (183) 183
tuberculosis - drug therapy (183) 183
antimicrobial agents (181) 181
pharmacodynamics (181) 181
anti-infective agents - therapeutic use (180) 180
medicine & public health (179) 179
bacterial infections and mycoses (176) 176
time factors (174) 174
in-vitro activity (173) 173
mice (172) 172
fluoroquinolones - administration & dosage (171) 171
quinolines - pharmacokinetics (171) 171
anti-bacterial agents - adverse effects (170) 170
aza compounds - pharmacokinetics (170) 170
prospective studies (169) 169
drug resistance in microorganisms (168) 168
azithromycin (164) 164
management (164) 164
medicine (163) 163
double-blind method (162) 162
administration, oral (157) 157
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4255) 4255
French (58) 58
Spanish (50) 50
German (35) 35
Korean (30) 30
Chinese (14) 14
Japanese (14) 14
Turkish (11) 11
Italian (7) 7
Russian (7) 7
Portuguese (4) 4
Croatian (2) 2
Czech (2) 2
Polish (2) 2
Bosnian (1) 1
Dutch (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2019, Volume 380, Issue 13, pp. 1201 - 1213
Journal Article
Journal Article
Journal Article
The Journal of infectious diseases, ISSN 1537-6613, 2018, Volume 217, Issue 4, pp. 628 - 636
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 02/2015, Volume 60, Issue 4, pp. 549 - 556
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2019, Volume 63, Issue 7
Journal Article
Journal of nanobiotechnology, ISSN 1477-3155, 2019, Volume 17, Issue 1, pp. 103 - 16
Background Immunocompromised individuals and those with lung dysfunction readily acquire pulmonary bacterial infections, which may cause serious diseases and... 
DEFENSE | ROS-responsive | Antibacterial nanotherapy | FOLATE RECEPTOR | MACROPHAGE | NANOSCIENCE & NANOTECHNOLOGY | BIODISTRIBUTION | CANCER | Pulmonary infection | POLYMERIC NANOPARTICLES | THERAPY | Targeted delivery | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | BACTERIAL-INFECTION | CYSTIC-FIBROSIS | LIPOSOMES | Multifunctional nanomedicine | Lung - microbiology | Cyclodextrins - metabolism | Reactive Oxygen Species - metabolism | Nanoparticles - chemistry | Humans | Delayed-Action Preparations - chemistry | Moxifloxacin - administration & dosage | Pneumonia, Bacterial - metabolism | Drug Delivery Systems | Anti-Bacterial Agents - therapeutic use | Pseudomonas Infections - metabolism | Nanoparticles - metabolism | Cyclodextrins - chemistry | Female | Lung - metabolism | A549 Cells | Pseudomonas Infections - drug therapy | Moxifloxacin - pharmacokinetics | Pseudomonas aeruginosa - drug effects | Delayed-Action Preparations - metabolism | Moxifloxacin - therapeutic use | Animals | Anti-Bacterial Agents - pharmacokinetics | Pneumonia, Bacterial - drug therapy | RAW 264.7 Cells | Mice | Anti-Bacterial Agents - administration & dosage | Usage | Antibiotics | Staphylococcus aureus infections | Research | Diagnosis | Macrophages | Staphylococcus aureus | Risk factors | Scientific equipment and supplies industry | Bacterial infections | Lung diseases | Cyclodextrins | Antibacterial agents | Folic acid | Homeopathy | Materia medica and therapeutics | Infection | Nanoparticles | Therapeutics | Bacteria | Health aspects | Drug delivery systems | Hydrogen peroxide | Cytotoxicity | Infections | Mucus | Moxifloxacin | Tissues | Bacterial diseases | Polyethylene glycol | Antibacterial activity | Pseudomonas aeruginosa | Controlled release | Pathogens | Inflammation | Cyclodextrin | Acids | Lungs | Sputum | Payloads
Journal Article
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 08/2018, Volume 37, Issue 8, pp. e207 - e213
Journal Article
Saudi Journal of Ophthalmology, ISSN 1319-4534, 04/2019, Volume 33, Issue 2, pp. 163 - 164
Corneal deposits have been reported with numerous topical medications including fluoroquinolones. However, they have not been documented as a side effect of... 
Corneal deposits | Fluoroquinolone | Moxifloxacin
Journal Article
Clinical Neurology, ISSN 0009-918X, 2016, Volume 56, Issue 5, pp. 344 - 347
Journal Article
Ophthalmology, ISSN 0161-6420, 2017, Volume 124, Issue 6, pp. 768 - 775
Purpose To compare the postoperative endophthalmitis rate before and after initiation of intracameral (IC) moxifloxacin prophylaxis for both... 
Ophthalmology | EYE | POSTOPERATIVE ENDOPHTHALMITIS | EFFICACY | SAFETY | INJECTION | PHACOEMULSIFICATION | INCISION CATARACT-SURGERY | OPHTHALMOLOGY | CEFUROXIME | ANTIBIOTIC-PROPHYLAXIS | ASCRS MEMBER SURVEY | Eye | Endophthalmitis | Moxifloxacin | Surgery
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 12/2018, Volume 44, Issue 12, pp. 2229 - 2231
(3) 0000 0001 1941 5140, grid.9970.7, Department of Anesthesiology and Intensive Care Medicine, Kepler University Hospital, Johannes Kepler University Linz,... 
THERAPY | RIFAMPICIN | MOXIFLOXACIN | CRITICAL CARE MEDICINE | Tuberculosis
Journal Article